Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia in men aged 46 is not significantly linked to depression, anxiety, quality of life, self-esteem, or sexual symptoms.

Testosterone boosts physical performance, grip strength, and lean body mass in older men with low testosterone.

Male pattern baldness might have evolved to help protect against prostate cancer by increasing UV radiation on the scalp.

Men with hair loss and shorter height may be perceived as less attractive.

More men are getting cosmetic surgery, with Botox and hair removal being popular, but these procedures have risks.

Men can have genetic risks for PCOS-related traits like obesity and diabetes.

Men's fertility and sexual health decline with age, with reduced testosterone and virility, and many lose fertility by their eighties.

Reduced sexual drive may be linked to male breast cancer, while anti-estrogenic factors might lower the risk.

Higher BMI and lower testosterone are linked to more aggressive prostate cancer.

Men are an untapped market for facial cosmetic procedures, with a rise in nonsurgical treatments and potential for growth in older age groups.

Gender identity doesn't determine who people are attracted to or their sexual practices.

Testosterone can cause acne and male-pattern baldness, affects hair growth in men and women, and makes male skin more sensitive.

Caucasian men have more chest hair and higher levels of certain androgen products than Chinese men.

Male and female mice have different skin thickness, and hormones affect their skin and hair growth differently.

Male androgenetic alopecia (MAA) is a common, hereditary hair loss condition in men, linked to heart disease, and can be treated with minoxidil, finasteride, or hair transplantation.

Anabolic steroid abuse can cause sexual, fertility, and health problems.

Older men with lower levels of available testosterone are more likely to be frail.

Testosterone treatment in trans men increases body and facial hair and may lead to hair loss over time, but severe skin issues are rare.

Hormonal status from androgen deprivation therapy may affect COVID-19 severity in men.

Sex hormone treatments can increase muscle mass in older adults but have inconsistent effects on muscle function and may carry cardiovascular risks.

Some men with early hair loss may have a male version of PCOS, affecting hormones and increasing health risks.

Early balding in men might be a male hormonal equivalent of polycystic ovaries syndrome in women.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Parental support and gender-affirming care are crucial for the mental health of transgender adolescents.

Men are increasingly using energy-based skin treatments for workplace success, with lasers and other devices effectively improving skin and body appearance.

The article suggests that the view of male baldness as a medical issue is influenced by commercial bias and calls for more unbiased research.

Adolescent sexual development should focus on positive aspects, including biological, psychological, and contextual factors, and recognize individual differences and the role of pleasure.